Fluorescein (medical use)
Fluorescein is used to help in the diagnosis of a number of eye problems.[2] When applied as a drop or within a strip of paper to the surface of the eye it is used to help detect eye injuries such as foreign bodies and corneal abrasions.[3][4] When given by mouth or injection into a vein it is used to help evaluate the blood vessels in the back of the eye during fluorescein angiography.[2][5]
Fluorescein drops being put in the eye before examination | |
Clinical data | |
---|---|
Pronunciation | FLURE-a-seen |
Trade names | Fluorescite, AK-Fluor, BioGlo, others |
License data |
|
Routes of administration | Eye drops, intravenous, by mouth |
Drug class | Diagnostic agent |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII |
|
KEGG | |
ChEBI | |
ChEMBL | |
PDB ligand | |
Chemical and physical data | |
Formula | C20H12O5 |
Molar mass | 332.311 g·mol−1 |
3D model (JSmol) | |
| |
|
When applied to the surface of the eye side effects may include a brief period of blurry vision and discoloration of contact lenses of the soft type.[6][2] When used by mouth or injection side effects may include headache, nausea, and a change to the color of the skin for a brief period of time.[2] Allergic reactions may rarely occur.[2] Fluorescein is a dye which is taken up by damaged cornea such that the area appears green under cobalt blue light.[2] There is also a version that comes premixed with lidocaine.[3][7]
Fluorescein was first made in 1871.[8] It is on the World Health Organization's List of Essential Medicines.[9]
Brand names
It is also sold as a combination drug with oxybuprocaine under the brand name Altafluor Benox.[10][11]
Other animals
It is also sometimes administered to pets in multi-pet environments to determine which pet needs behavioral modification.
References
- "Fluorescein sodium 100 mg/ml, solution for injection - Summary of Product Characteristics (SmPC)". (emc). 16 January 2018. Retrieved 11 March 2020.
- Duvall, Brian; Kershner, Robert M. (2006). Ophthalmic Medications and Pharmacology. SLACK Incorporated. p. 29. ISBN 9781556427503. Archived from the original on 18 January 2017.
- British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. pp. 769, 772. ISBN 9780857111562.
- Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 416. ISBN 9781284057560.
- "Anatera 100mg/ml solution for injection - Summary of Product Characteristics (SmPC)". (emc). 10 February 2020. Retrieved 11 March 2020.
- World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 314. hdl:10665/44053. ISBN 9789241547659.
- "Minims Lidocaine & Fluorescein Summary of Product Characteristics (SmPC) - (emc)". (emc). 23 October 2017. Retrieved 11 March 2020.
- Bartlett, Jimmy D.; Jaanus, Siret D. (2008). Clinical Ocular Pharmacology. Elsevier Health Sciences. p. 283. ISBN 0750675764. Archived from the original on 18 January 2017.
- World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- "Drug Approval Package: Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution)". U.S. Food and Drug Administration (FDA). 9 April 2018. Retrieved 11 March 2020.
- "Altafluor- fluorescein sodium and benoxinate hydrochloride solution". DailyMed. 4 December 2017. Retrieved 10 March 2020.
External links
- "Fluorescein". Drug Information Portal. U.S. National Library of Medicine.
- "Fluorescein sodium". Drug Information Portal. U.S. National Library of Medicine.